FDA Law Blog: September 29, 2015 Back from Break: FDA Issues Letter to Pathway Genomics for Cancer Screening LDT; Proposed Legislative Alternatives to FDA Framework Continue to Emerge By Jamie K. Wolszon & Jeffrey N. Gibbs –

http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/09/back-from-break-fda-issues-letter-to-pathway-genomics-for-cancer-screening-ldt-proposed-legislative-.html?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+FdaLawBlog+%28FDA+Law+Blog%29